medigraphic.com
ISSN 1561-3046 (Electronic)

2014, Number 1

<< Back Next >>

Rev Cub Med Mil 2014; 43 (1)

Characterization of carotid atherosclerosis in patients with metabolic syndrome

Hinojosa RI, Solís AL

Language: Spanish
References: 28
Page:
PDF size: 166.16 Kb.


ABSTRACT

Objective: characterize carotid atherosclerotic lesions in patients with metabolic syndrome.
Methods: a prospective descriptive study was conducted of 128 patients with a clinical diagnosis of metabolic syndrome. Carotid echo-Doppler was performed to describe intima media thickness, location and type of atheromatous plaques, stenosis degree and atherogenic index, followed by liver ultrasonography for steatosis and details about its extent.
Results: atherosclerotic damage was similar in both carotid axes. Low shear stress areas were the most seriously affected, with a predominance of type III atheromatous plaque. Most atherogenic risk factors were related to increased intima media thickness, an atherogenic index below 1, and a low prevalence of significant stenosis. There was a predominance of increased abdominal circumference and severe hepatic steatosis. A positive, relevant correlation was found between the extent of carotid atherosclerotic damage and the degree of central and body obesity.
Conclusions: there was a positive, relevant correlation between the extent of carotid atherosclerotic damage and the degree of central and body obesity. Most atherogenic risk factors were related to increased intima media thickness, an atherogenic index below 1, and a low prevalence of significant stenosis. Age over 60 and hypertension were the predominant risk factors.


REFERENCES

  1. Diabetes Atlas. 2nd ed. Brussels: International Diabetes Federation; 2003.

  2. Rguibi M, Belahsen R. Metabolic syndrome among urban Sahraoui women of South Morocco. Am J Human Biol. 2004;16:598-601.

  3. Simmons D, Thompson CF. Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent. Diabetes Care. 2004;27:3002-4.

  4. Eckel RH, Grundy SM. The Metabolic Syndrome. Lancet. 2005;365:1415-28.

  5. Alegría Ezquerra E, Castellano Vázquez JM, Alegría Barrero A. Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica. Rev Esp Cardiol. 2008;61(7):752-64

  6. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Rev Endocronol. 2008;29:777-822.

  7. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629-36.

  8. Ingino C, Cura M, Machado R, Pulido J, Archer M, Cherro A et al. Utilidad de la presencia y el tipo de placa carotídea en la predicción de eventos cardiovasculares en pacientes de riesgo alto. Rev Argent Cardiol [Internet] 2011; [citado 13 Feb 2013];79(2):139-147. Disponible en: http://www.scielo.org.ar/pdf/rac/v79n2/v79n2a08.pdf

  9. Tanaka H, Nishino M, Ishida M, Fukunaga R, Sueyoshi K. Progression of carotid atherosclerosis in Japanese patients with coronary artery disease. Stroke. 1992;23:946-51.

  10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)". JAMA. 2001;285:2486-96.

  11. Csendes PG, Paolinelli PG, Busel MD, Venturelli VA, Rodríguez J. Hígado graso: ultrasonido y correlación anatomopatológica. Rev Chilena Radiol. 2004;10(2):50-2.

  12. Scottish Intercollegiate Guidelines Networt (SIGN). Acute Coronary Syndromes [Internet]. 2007 [cited 2013 Feb 13];94. Disponible en: http://www.sign.ac.uk/pdf/sign93.pdf

  13. González López A, Arrieta T, Solís Alfonso L, Pérez Pérez M, Ramírez Simonó M. Estudio con ultrasonido Doppler color en la caracterización de la enfermedad aterosclerótica carotídea oclusiva sintomática. Rev Chilena Radiol. 2009;15(3):110-21.

  14. Noticias en medicina. Relación entre las tres definiciones comunes del síndrome metabólico y la aterosclerosis carotídea subclínica [Internet]. 2009 [citado 13 Feb 2013]. Disponible en: http://www.blog-medico.com.ar/prevencion-y-promocion-desalud/ sindrome-metabolico-y-ateroesclerosis-carotidea.htm

  15. Acevedo M, Arnaiz P, Corbalán R, Godoy I, Morales P, Chalhub M, et al. Modificación del grosor intima-media carotídeo según factores de riesgo clásicos y síndrome metabólico con o sin inflamación. Rev Chil Cardiol. 2009;28(4):337-48.

  16. Hassinen M, Komulainen P, Lakka TA. El síndrome metabólico como factor de riesgo cardiovascular. Sociedad Iberoamericana de información científica. Arch Int Med. 2006;166(4):444-9.

  17. Maksimovic M. Frecuencia y características del síndrome metabólico en pacientes con estenosis carotídea sintomática. Rev Med Chile. 2009;137(3):329-36.

  18. Krebs Carol A, Vishan L, Giyanani MD, Ronald L, Eisenberg MD. Doppler Color. Madrid: Marbán; 2001. p. 52-102.

  19. Ministerio de Salud Pública (MINSAP). Programa Nacional de prevención y control de las enfermedades cerebrovasculares (ECV). La Habana: MINSAP; 2005. [citado 13 Feb 2013]. Disponible en:http://aps.sld.cu/E/pro=cv.htm

  20. Vázquez Vigoa A, Vázquez Cruz A, Calderón RO, Buchaca EF, Cruz Álvarez NM, Jiménez R, et al. Síndrome metabólico en pacientes hipertensos esenciales. Nefrología. 2003;XXIII(5);423-31.

  21. Mergarejo Rojas E. Disfunción endotelial, aterogénesis y aterotrombosis. 2010. [citado 13 Feb 2013]. Disponible en: http://www.scc.org.co/libros/ANTICOAGULACION/paginas%205-12.pdf

  22. Cardona F, Tinahones FJ. Relación entre la lipemia posprandial y la aterosclerosis. De la práctica a la clínica. Rev Nutr Clín Med. 2008;II(1):1-11.

  23. Ferns G, Keti V. HDL-cholesterol modulation and its impact on the management of cardiovascular risk. Ann Clin Biochem. 2008;45:122-8.

  24. Guembe MJ, Toledo E, Barba J, Martínez Vila E, González-Diego P, Irimia P, et al. Asociación entre el síndrome metabólico o sus constituyentes y el incremento del índice íntima-media carotídeo y de la masa ventricular izquierda. Estudio Rivana. Aterosclerosis 2010. [citado 13 Feb 2013]. Disponible en:http://www.searteriosclerosis.org/resources/archivosbd/formacion_congresos_docu mentos/1f68c814d51746efbfe97e0c6de33306.pdf

  25. Santini F, Giannetti M, Mazzeo S. La Esteatosis Hepática debe ser Incluida entre los hallazgos característicos del Síndrome Metabólico. J Endocrinol Invest. 2007;30(2):104-10.

  26. Finn AV, Kolodgie FD, Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol. 2010;30:177-81.

  27. Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. La estenosis hepática está asociada con la arteriosclerosis carotídea. Un estudio caso-control. Arterioscler Thromb Vasc Biol. 2005;25:1045-50.

  28. Mohammadi A, Bazazi A, Ghasemi Rad M. Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease. Int J Gen Med. 2011;4:717-22.




2020     |     www.medigraphic.com